BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 24062531)

  • 1. Microtubule depolymerization activates the Epstein-Barr virus lytic cycle through protein kinase C pathways in nasopharyngeal carcinoma cells.
    Liu YR; Huang SY; Chen JY; Wang LH
    J Gen Virol; 2013 Dec; 94(Pt 12):2750-2758. PubMed ID: 24062531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr Virus (EBV) Tegument Protein BGLF2 Promotes EBV Reactivation through Activation of the p38 Mitogen-Activated Protein Kinase.
    Liu X; Cohen JI
    J Virol; 2016 Jan; 90(2):1129-38. PubMed ID: 26559845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of class I histone deacetylases by romidepsin potently induces Epstein-Barr virus lytic cycle and mediates enhanced cell death with ganciclovir.
    Hui KF; Cheung AK; Choi CK; Yeung PL; Middeldorp JM; Lung ML; Tsao SW; Chiang AK
    Int J Cancer; 2016 Jan; 138(1):125-36. PubMed ID: 26205347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Epstein-Barr virus reactivation in nasopharyngeal carcinoma cells by dietary sulforaphane.
    Wu CC; Chuang HY; Lin CY; Chen YJ; Tsai WH; Fang CY; Huang SY; Chuang FY; Lin SF; Chang Y; Chen JY
    Mol Carcinog; 2013 Dec; 52(12):946-58. PubMed ID: 22641235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus infection induces indoleamine 2,3-dioxygenase expression in human monocyte-derived macrophages through p38/mitogen-activated protein kinase and NF-κB pathways: impairment in T cell functions.
    Liu WL; Lin YH; Xiao H; Xing S; Chen H; Chi PD; Zhang G
    J Virol; 2014 Jun; 88(12):6660-71. PubMed ID: 24696473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ERK/c-Jun Recruits Tet1 to Induce Zta Expression and Epstein-Barr Virus Reactivation through DNA Demethylation.
    Zhang W; Han D; Wan P; Pan P; Cao Y; Liu Y; Wu K; Wu J
    Sci Rep; 2016 Oct; 6():34543. PubMed ID: 27708396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Novel Small Organic Compounds with Diverse Structures for the Induction of Epstein-Barr Virus (EBV) Lytic Cycle in EBV-Positive Epithelial Malignancies.
    Choi CK; Ho DN; Hui KF; Kao RY; Chiang AK
    PLoS One; 2015; 10(12):e0145994. PubMed ID: 26717578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin.
    Ramayanti O; Juwana H; Verkuijlen SA; Adham M; Pegtel MD; Greijer AE; Middeldorp JM
    Int J Cancer; 2017 Jan; 140(1):149-162. PubMed ID: 27600027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (-)-Epigallocatechin-3-gallate inhibition of Epstein-Barr virus spontaneous lytic infection involves ERK1/2 and PI3-K/Akt signaling in EBV-positive cells.
    Liu S; Li H; Chen L; Yang L; Li L; Tao Y; Li W; Li Z; Liu H; Tang M; Bode AM; Dong Z; Cao Y
    Carcinogenesis; 2013 Mar; 34(3):627-37. PubMed ID: 23180656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus-driven metabolic alterations contribute to the viral lytic reactivation and tumor progression in nasopharyngeal carcinoma.
    Shi F; Shang L; Zhou M; Lv C; Li Y; Luo C; Liu N; Lu J; Tang M; Luo X; Xu J; Fan J; Zhou J; Gao Q; Wu W; Jia W; Wang H; Cao Y
    J Med Virol; 2024 May; 96(5):e29634. PubMed ID: 38682578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of lytic cycle of Epstein-Barr virus by suberoylanilide hydroxamic acid leads to apoptosis and tumor growth suppression of nasopharyngeal carcinoma.
    Hui KF; Ho DN; Tsang CM; Middeldorp JM; Tsao GS; Chiang AK
    Int J Cancer; 2012 Oct; 131(8):1930-40. PubMed ID: 22261816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EBV Infection and Glucose Metabolism in Nasopharyngeal Carcinoma.
    Zhang J; Jia L; Tsang CM; Tsao SW
    Adv Exp Med Biol; 2017; 1018():75-90. PubMed ID: 29052133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. X-box-binding protein 1 activates lytic Epstein-Barr virus gene expression in combination with protein kinase D.
    Bhende PM; Dickerson SJ; Sun X; Feng WH; Kenney SC
    J Virol; 2007 Jul; 81(14):7363-70. PubMed ID: 17494074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus induction of the Hedgehog signalling pathway imposes a stem cell phenotype on human epithelial cells.
    Port RJ; Pinheiro-Maia S; Hu C; Arrand JR; Wei W; Young LS; Dawson CW
    J Pathol; 2013 Nov; 231(3):367-77. PubMed ID: 23934731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle.
    Gradoville L; Kwa D; El-Guindy A; Miller G
    J Virol; 2002 Jun; 76(11):5612-26. PubMed ID: 11991990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PKC theta and p38 MAPK activate the EBV lytic cycle through autophagy induction.
    Gonnella R; Granato M; Farina A; Santarelli R; Faggioni A; Cirone M
    Biochim Biophys Acta; 2015 Jul; 1853(7):1586-95. PubMed ID: 25827954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the LKB1-AMPK pathway by the Epstein-Barr virus-encoded LMP1 promotes proliferation and transformation of human nasopharyngeal epithelial cells.
    Lo AK; Lo KW; Ko CW; Young LS; Dawson CW
    J Pathol; 2013 Jul; 230(3):336-46. PubMed ID: 23592276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus Zta-induced immunomodulators from nasopharyngeal carcinoma cells upregulate interleukin-10 production from monocytes.
    Lee CH; Yeh TH; Lai HC; Wu SY; Su IJ; Takada K; Chang Y
    J Virol; 2011 Jul; 85(14):7333-42. PubMed ID: 21543473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EBV reactivation as a target of luteolin to repress NPC tumorigenesis.
    Wu CC; Fang CY; Hsu HY; Chuang HY; Cheng YJ; Chen YJ; Chou SP; Huang SY; Lin SF; Chang Y; Tsai CH; Chen JY
    Oncotarget; 2016 Apr; 7(14):18999-9017. PubMed ID: 26967558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LMP1 Increases Expression of NADPH Oxidase (NOX) and Its Regulatory Subunit p22 in NP69 Nasopharyngeal Cells and Makes Them Sensitive to a Treatment by a NOX Inhibitor.
    Sun J; Hu C; Zhu Y; Sun R; Fang Y; Fan Y; Xu F
    PLoS One; 2015; 10(8):e0134896. PubMed ID: 26244812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.